SUD Science Essentials for CASAC
Key Takeaways
- The disease model views addiction as a chronic, relapsing brain condition — not a moral failing
- DSM-5-TR diagnoses substance use disorder on a severity continuum using 11 criteria (tolerance and withdrawal among them)
- Dopamine drives the reward pathway; repeated use hijacks motivation and impulse control
- Alcohol and benzodiazepine withdrawal can be life-threatening; opioid withdrawal is severe but rarely fatal alone
- FDA-approved MOUD for opioid use disorder: methadone, buprenorphine, and naltrexone
Science Principles Every CASAC Candidate Needs
Although IC&RC lists Education, Documentation, and Continuing Care as its own domain, scientific principles of substance use appear throughout the CASAC item bank. Accurate psychoeducation and sound clinical judgment depend on the same facts the exam tests: neurobiology, diagnostic criteria, withdrawal, and evidence-based pharmacotherapy.
Models of Addiction
| Model | Core idea | Counseling implication |
|---|---|---|
| Disease model | Chronic, progressive brain disease | Reduces stigma; long-term treatment |
| Biopsychosocial | Biology + psychology + environment | Comprehensive assessment |
| Behavioral / learning | Reinforced patterns | Skills training, contingency management |
| Moral model (outdated) | Character weakness | Not evidence-based — exam distractor |
The disease model — addiction as a chronic, relapsing condition requiring treatment — is widely accepted in OASAS and IC&RC frameworks. It does not mean the person has zero agency; it explains why abstinence-only willpower often fails without support.
DSM-5-TR Substance Use Disorder
DSM-5-TR replaced separate "abuse" and "dependence" diagnoses with one substance use disorder rated mild (2–3 criteria), moderate (4–5), or severe (6+). Eleven criteria include:
- Hazardous use, social/interpersonal problems, neglected roles
- Tolerance — needing more for the same effect
- Withdrawal — symptoms when stopping (or using to avoid withdrawal)
- Craving, failed attempts to cut down, time spent obtaining/using, physical/psychological problems, abandoned activities, continued use despite harm
Tolerance and withdrawal were hallmarks of old "dependence" — still critical exam facts even under the unified diagnosis.
Neurobiology: Reward Pathway
Dopamine is the neurotransmitter most associated with the brain's reward system. Natural rewards (food, social connection) release dopamine at baseline levels. Drugs of misuse can cause a surge far above normal, reinforcing drug-seeking over healthier rewards. With repeated use, the brain may produce less natural dopamine, driving craving and anhedonia in early recovery — a science fact counselors use to normalize post-acute withdrawal experiences.
Withdrawal by Substance Class
| Class | Withdrawal severity | Exam highlight |
|---|---|---|
| Alcohol / CNS depressants (benzos) | Can be life-threatening (seizures, delirium tremens) | Requires medically supervised detox |
| Opioids | Very distressing (rhinorrhea, myalgias, GI upset) | Rarely fatal alone; still needs support |
| Stimulants | Crash, depression, fatigue | Supportive care; watch for depression/suicide |
| Cannabis | Irritability, sleep disturbance | Uncomfortable, not typically deadly |
Naloxone (Narcan) is an opioid antagonist — it displaces opioids from receptors to reverse respiratory depression in overdose. Effects last roughly 30–90 minutes; re-sedation is possible with long-acting opioids.
Medications Counselors Must Know
Counselors do not prescribe, but they educate and support adherence:
| Disorder | FDA-approved medications (representative) |
|---|---|
| Opioid use disorder | Methadone (full agonist), buprenorphine (partial agonist), naltrexone (antagonist) |
| Alcohol use disorder | Disulfiram, acamprosate, naltrexone |
Do not confuse naloxone (overdose rescue) with naltrexone (maintenance antagonist). Clonidine may ease symptoms but is not an FDA-approved MOUD.
Process Addictions and Co-Occurring Context
Process addictions (gambling disorder, etc.) involve compulsive behavior without a substance — still relevant to biopsychosocial formulation. Co-occurring mental health disorders are the norm, not the exception; science literacy supports integrated treatment language.
DSM-5 Severity in Practice
Severity guides level of care conversations:
- Mild — outpatient may suffice with strong supports
- Moderate — IOP or structured outpatient often indicated
- Severe — residential or medically managed care may be needed, especially with withdrawal risk
Counselors do not assign DSM codes independently in all settings, but they must recognize criteria during assessment and education.
Co-Occurring Disorders and Integrated Care
Dual diagnosis, co-occurring disorders, and comorbidity all describe SUD plus mental health conditions. Integrated treatment addresses both simultaneously rather than demanding "28 days clean before psychiatric care." Untreated depression or PTSD undermines psychoeducation about relapse risk.
Alcohol Pharmacotherapy Basics
| Medication | Mechanism (simplified) | Counselor role |
|---|---|---|
| Disulfiram | Aversive reaction if alcohol consumed | Stress adherence, avoid alcohol-containing products |
| Acamprosate | Stabilizes neurochemistry post-acute withdrawal | Support daily adherence |
| Naltrexone | Reduces craving/reward from alcohol (and opioids in MOUD form) | Monitor motivation; note opioid sensitivity rules for opioid patients |
Stimulant and Cannabis Science Notes
Stimulant use disorders lack FDA-approved medications comparable to MOUD; treatment emphasizes behavioral therapies, contingency management, and addressing co-occurring ADHD or depression when present. Cannabis withdrawal exists (irritability, vivid dreams, sleep disruption) — counselors should not dismiss it as "not real addiction" on exams or in groups.
Fentanyl and Overdose Education
Given the opioid supply crisis, psychoeducation must cover fentanyl contamination, rapid overdose, and multiple naloxone doses. Counselors distribute or refer to community naloxone programs per state law and agency policy. Clients who use alone face elevated fatality risk — education should address never-use-alone agreements and buddy check-ins.
Teaching Science Without Jargon
Translate research into client language: "Your brain adapted to expect the drug's dopamine spike; recovery is retraining the reward system." That sentence is psychoeducation and exam-ready science — the overlap this chapter domain expects. When clients ask "Am I weak?" science-based education reframes the question toward treatable brain adaptation and recoverable skills.
Which statement best reflects the disease model of addiction tested on CASAC?
A client needs increasing doses of oxycodone to achieve the same pain relief as last year. This is called:
Which substance classes have withdrawal syndromes that can be life-threatening and require medically supervised detoxification?
Which three medications are FDA-approved for treating opioid use disorder?